EpiTherapeutics

EpiTherapeutics

EpiTherapeutics

EpiTherapeutics is developing novel innovative cancer drugs based on world leading research in epigenetics.
Founded
2008
Follow us
Alexa global traffic share
Acquired by
Gilead Sciences
1
06 May 2015
$65,000,000
Location
Headquarters
$65,000,000
VentureWire

Gilead to Buy EpiTherapeutics for $65M

Funding